MO4-1 Management of infusion-related reactions in patients receiving amivantamab in the CHRYSALIS study

Park, K., Sabari, J., Haura, E. B., Shu, C. A., Spira, A., Salgia, R., Reckamp, K. L., Sanborn, R. E., Govindan, R., Bauml, J. M., Curtin, J. C., Xie, J., Roshak, A., Lorenzini, P., Millington, D., Thayu, M., Knoblauch, R. E., & Cho, B. C. (2022). MO4-1 Management of infusion-related reactions in patients receiving amivantamab in the CHRYSALIS study. Annals of Oncology, 33, S482. https://doi.org/10.1016/j.annonc.2022.05.104
Authors:
Keunchil Park
Joshua K. Sabari
Eric B. Haura
Catherine A. Shu
Alexander I. Spira
Ravi Salgia
Karen L. Reckamp
Rachel E. Sanborn
Ramaswamy Govindan
Joshua Bauml
Joshua C. Curtin
John Xie
Amy Roshak
Patricia Lorenzini
Dawn Millington
Meena Thayu
R.E. Knoblauch
Byoung Chul Cho
Affiliated Authors:
Catherine A. Shu
Columbia Affiliation:
Subjects:
Advancements in Lung Cancer Research (OpenAlex Topic)
Pharmacokinetics of Antibiotics in Critically Ill Patients (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/j.annonc.2022.05.104
DOI:
10.1016/j.annonc.2022.05.104
Journal:
Annals of Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: